Literature DB >> 16038767

Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood-brain barrier.

Selwa Alsam1, James Sissons, Samantha Jayasekera, Naveed Ahmed Khan.   

Abstract

OBJECTIVES: Granulomatous amoebic encephalitis (GAE) is a serious human infection with fatal consequences, however, the pathogenic mechanisms associated with this disease remain unclear. Several lines of evidence suggest that haematogenous spread is a prerequisite for Acanthamoeba encephalitis but it is not clear how circulating amoebae cross the blood-brain barrier to gain entry into the central nervous system. Objectives of this study were to determine the effects of Acanthamoeba on the permeability of an in vitro blood-brain barrier model and factors contributing to these changes.
METHODS: Using human brain microvascular endothelial cells, an in vitro blood-brain barrier model was constructed in 24-well Transwell plates. Acanthamoeba (GAE isolate belonging to T1 genotype) or its conditioned media were used to determine permeability changes. Zymography assays were performed to characterise Acanthamoeba proteases. In addition, the ability of Acanthamoeba to bind brain microvascular endothelial cells was determined using adhesion assays.
RESULTS: We observed that Acanthamoeba produced an increase of more than 45% in the blood-brain barrier permeability. Acanthamoeba-conditioned media exhibited similar effects indicating Acanthamoeba-mediated blood-brain barrier permeability is contact-independent. Prior treatment of conditioned media with phenylmethyl sulfonyl fluoride (PMSF, serine protease inhibitor), abolished permeability changes indicating the role of serine proteases. Of interest, methyl alpha-d-mannopyranoside inhibited Acanthamoeba binding to human brain microvascular endothelial cells but had no effect on Acanthamoeba-mediated blood-brain barrier permeability. Zymography assays revealed that Acanthamoeba produced two major proteases, one of which was inhibited by PMSF (serine protease inhibitor) and the second with 1,10-phenanthroline (metalloprotease inhibitor).
CONCLUSIONS: We have for the first time shown that Acanthamoeba produces human brain microvascular endothelial cells permeability, which can be blocked by PMSF. A metalloprotease of approx. molecular weight of 150 kDa is produced by A. castellanii (GAE isolate belonging to T1 genotype) and its role in the disease is suggested.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038767     DOI: 10.1016/j.jinf.2004.09.001

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  16 in total

1.  Cytotoxic activity and degradation patterns of structural proteins by corneal isolates of Acanthamoeba spp.

Authors:  Viviane Peracini Sant'ana; Linda Christian Carrijo-Carvalho; Annette Silva Foronda; Ana Marisa Chudzinski-Tavassi; Denise de Freitas; Fábio Ramos Souza de Carvalho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-27       Impact factor: 3.117

2.  Extracellular protease profile of Acanthamoeba after prolonged axenic culture and after interaction with MDCK cells.

Authors:  Cecília Cirelli; Elaine Isabela Soares Mesquita; Isabela Aurora Rodrigues Chagas; Cinthia Furst; Cynara Oliveira Possamai; Jonatas Santos Abrahão; Ludmila Karen Dos Santos Silva; Marina Felipe Grossi; Carlos Alberto Tagliati; Adriana Oliveira Costa
Journal:  Parasitol Res       Date:  2019-12-17       Impact factor: 2.289

3.  Use of in vitro assays to determine effects of human serum on biological characteristics of Acanthamoeba castellanii.

Authors:  James Sissons; Selwa Alsam; Monique Stins; Antonio Ortega Rivas; Jacob Lorenzo Morales; Jane Faull; Naveed Ahmed Khan
Journal:  J Clin Microbiol       Date:  2006-07       Impact factor: 5.948

4.  Acanthamoeba culbertsoni elicits soluble factors that exert anti-microglial cell activity.

Authors:  Jenica L Harrison; Gabriela A Ferreira; Erinn S Raborn; Audrey D Lafrenaye; Francine Marciano-Cabral; Guy A Cabral
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

5.  Acanthamoeba produces disseminated infection in locusts and traverses the locust blood-brain barrier to invade the central nervous system.

Authors:  Parisa N Mortazavi; Graham Goldsworthy; Ruth Kirk; Naveed A Khan
Journal:  BMC Microbiol       Date:  2010-07-08       Impact factor: 3.605

6.  The role of Src kinase in the biology and pathogenesis of Acanthamoeba castellanii.

Authors:  Ruqaiyyah Siddiqui; Junaid Iqbal; Marie-Josée Maugueret; Naveed Ahmed Khan
Journal:  Parasit Vectors       Date:  2012-06-07       Impact factor: 3.876

7.  Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis.

Authors:  James Sissons; Selwa Alsam; Graham Goldsworthy; Mary Lightfoot; Edward L Jarroll; Naveed Ahmed Khan
Journal:  BMC Microbiol       Date:  2006-05-03       Impact factor: 3.605

8.  Essential Role for an M17 Leucine Aminopeptidase in Encystation of Acanthamoeba castellanii.

Authors:  Yu-Ran Lee; Byoung-Kuk Na; Eun-Kyung Moon; Su-Min Song; So-Young Joo; Hyun-Hee Kong; Youn-Kyoung Goo; Dong-Il Chung; Yeonchul Hong
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

9.  Proteases from Entamoeba spp. and Pathogenic Free-Living Amoebae as Virulence Factors.

Authors:  Jesús Serrano-Luna; Carolina Piña-Vázquez; Magda Reyes-López; Guillermo Ortiz-Estrada; Mireya de la Garza
Journal:  J Trop Med       Date:  2013-02-07

10.  Morpho-Physiological and Biochemical Criteria of Acanthamoeba spp. Isolated from the Egyptian Aquatic Environment.

Authors:  A Al-Herrawy; M Bahgat; A Mohammed; A Ashour; W Hikal
Journal:  Iran J Parasitol       Date:  2013-04       Impact factor: 1.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.